Fingerprint
Dive into the research topics of 'Off-label use of bevacizumab for the treatment of age-related macular degeneration: What is the evidence?'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Off-label use of bevacizumab for the treatment of age-related macular degeneration: What is the evidence?
Focke Ziemssen*, Salvatore Grisanti, Karl Ulrich Bartz-Schmidt, Martin S. Spitzer
*Corresponding author for this work
26
Citations
(Scopus)